The bioactive molecule sphingosine-1-phosphate (S1P) activates five recognized G-protein coupled receptors (S1P₁₋₅) to affect various tissues, including myocardium. Activation of these receptors and the ability to affect functional responses including differentiation, migration, contraction, and ionic currents in isolated cardiac fibroblasts (CFb) and myocytes was investigated. CFb are essential components of myocardium, and study of their cell signaling and physiology is required for a number of emerging disciplines. However, in order to conduct meaningful studies on CFb, methods for selective, reproducible cell isolations are necessary. A protocol was therefore developed that significantly reduced resident macrophage levels in CFb isolate...
Although c-kit(+) cardiac progenitor cells (CPCs) are currently used in clinical trials there remain...
13301乙第2090号博士(医学)金沢大学博士論文要旨Abstract 以下に掲載:PLOS ONE 2017. PLOS. 共著者:Sei-ichiro Ohkura, Soichiro Usui...
Although c-kit(+) cardiac progenitor cells (CPCs) are currently used in clinical trials there remain...
Following myocardial infarction (MI), cardiac fibroblasts (CF) proliferate, undergo myofibroblast tr...
The lysophospholipid sphingosine 1-phosphate (S1P) has been known for many years to induce cellular ...
Cardiac fibroblasts, together with cardiomyocytes, occupy the majority of cells in the myocardium an...
Modulation of Ca(2+) homoeostasis in cardiac myocytes plays a major role in beat-to-beat regulation ...
Sphingosine-1-phosphate (S1P) is a bioactive mediator in inflammation. Dysregulated S1P is demonstra...
Mathematical modeling has been used to explore the consequences of the actions of sphingosine-1-phos...
AbstractSphingosine-1-phosphate (S1P) is a biologically active sphingolipid metabolite that exerts i...
Abstract Sphingosine 1‐Phosphate receptor 1 (S1P1, encoded by S1pr1) is a G protein‐coupled receptor...
Although c-kit(+) cardiac progenitor cells (CPCs) are currently used in clinical trials there remain...
Mathematical modeling has been used to explore the consequences of the actions of sphingosine-1-phos...
Mathematical modeling has been used to explore the consequences of the actions of sphingosine-1-phos...
Mathematical modeling has been used to explore the consequences of the actions of sphingosine-1-phos...
Although c-kit(+) cardiac progenitor cells (CPCs) are currently used in clinical trials there remain...
13301乙第2090号博士(医学)金沢大学博士論文要旨Abstract 以下に掲載:PLOS ONE 2017. PLOS. 共著者:Sei-ichiro Ohkura, Soichiro Usui...
Although c-kit(+) cardiac progenitor cells (CPCs) are currently used in clinical trials there remain...
Following myocardial infarction (MI), cardiac fibroblasts (CF) proliferate, undergo myofibroblast tr...
The lysophospholipid sphingosine 1-phosphate (S1P) has been known for many years to induce cellular ...
Cardiac fibroblasts, together with cardiomyocytes, occupy the majority of cells in the myocardium an...
Modulation of Ca(2+) homoeostasis in cardiac myocytes plays a major role in beat-to-beat regulation ...
Sphingosine-1-phosphate (S1P) is a bioactive mediator in inflammation. Dysregulated S1P is demonstra...
Mathematical modeling has been used to explore the consequences of the actions of sphingosine-1-phos...
AbstractSphingosine-1-phosphate (S1P) is a biologically active sphingolipid metabolite that exerts i...
Abstract Sphingosine 1‐Phosphate receptor 1 (S1P1, encoded by S1pr1) is a G protein‐coupled receptor...
Although c-kit(+) cardiac progenitor cells (CPCs) are currently used in clinical trials there remain...
Mathematical modeling has been used to explore the consequences of the actions of sphingosine-1-phos...
Mathematical modeling has been used to explore the consequences of the actions of sphingosine-1-phos...
Mathematical modeling has been used to explore the consequences of the actions of sphingosine-1-phos...
Although c-kit(+) cardiac progenitor cells (CPCs) are currently used in clinical trials there remain...
13301乙第2090号博士(医学)金沢大学博士論文要旨Abstract 以下に掲載:PLOS ONE 2017. PLOS. 共著者:Sei-ichiro Ohkura, Soichiro Usui...
Although c-kit(+) cardiac progenitor cells (CPCs) are currently used in clinical trials there remain...